COVID vaccine: NTAGI holds meeting on Covovax inclusion as heterologous booster for adults on CoWin portal Ruchika Sharma10 Feb 2023 2:54 PM ISTNew Delhi: National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of Covid-19 vaccine Covovax as...
Serum Institute seeks inclusion of Covovax in CoWIN portal as heterologous booster dose for adults: Sources Ruchika Sharma19 Jan 2023 1:45 PM ISTCovovax is manufactured through technology transfer from Novavax.
SII Cervical cancer vaccine CERVAVAC likely to be launched in April next year Ruchika Sharma15 Dec 2022 1:00 PM ISTSerum Institute's vaccine is likely to be available at a much lower rate.
Gap between 2nd dose, precaution dose of COVID vaccines reduced on NTAGI recommendation, informs Govt Roshni Dhar8 Aug 2022 6:30 PM ISTBased on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the precaution...
Health Bulletin 8/ August/ 2022 Roshni Dhar8 Aug 2022 5:15 PM ISTHere are the Top Health stories for the day:NMC directs all medical colleges to register with All India Survey on Higher Education, get AISHE...
Govt informs gap between 2nd dose, precaution dose of COVID vaccines reduced on NTAGI recommendation Ruchika Sharma7 Aug 2022 3:15 PM ISTNew Delhi: Based on the recommendations made by the National Technical Advisory Group on Immunisation (NTAGI), the interval between the second and the...
NTAGI panel reviews data for Biological E Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma22 July 2022 3:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Corbevax, is currently being used to inoculate children in the age group of 12 to 14...
NTAGI to discuss data of Gennova Pharma mRNA vaccine against COVID Ruchika Sharma12 July 2022 1:00 PM ISTThe indigenous innovative mRNA vaccine is based on the second wave driven by the Delta variant and can be kept under 2 to 8 degrees Celsius this means...
Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma27 Jun 2022 11:29 AM ISTNew Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...
NTAGI recommends coronavirus precaution dose before 9 months for those travelling abroad Ruchika Sharma7 May 2022 3:04 PM ISTThe sources further said that no recommendation has been made for reducing the gap in booster doses for everybody.
Serum Institute Covovax price slashed to Rs 225 Per Dose Roshni Dhar4 May 2022 5:51 PM ISTA day after its Covid shot Covovax was included on the CoWIN portal for inoculation of children aged 12-17 years at private vaccination centres, the...
Health Bulletin 4/May/2022 Roshni Dhar4 May 2022 5:24 PM ISTHere are the top health stories for the day: Mandatory yoga for MBBS: NMC releases common yoga protocol to be followed by allReferring to...
